A Comprehensive Review of the 1H-MRS Metabolite Spectrum in Autism Spectrum Disorder
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Neuroimaging studies of neuropsychiatric behavior biomarkers across spectrum disorders are typically based on diagnosis, thus failing to account for the heterogeneity of multi-dimensional spectrum disorders such as autism (ASD). Control group trait phenotypes are also seldom reported. Proton magnetic resonance spectroscopy ((1)H-MRS) measures the abundance of neurochemicals such as neurotransmitters and metabolites and hence can probe disorder phenotypes at clinical and sub-clinical levels. This detailed review summarizes and critiques the current (1)H-MRS research in ASD. The literature reports reduced N-acetylaspartate (NAA), glutamate and glutamine (Glx), γ-aminobutyric acid (GABA), creatine and choline, and increased glutamate for children with ASD. Adult studies are few and results are inconclusive. Overall, the literature has several limitations arising from differences in (1)H-MRS methodology and sample demographics. We argue that more consistent methods and greater emphasis on phenotype studies will advance understanding of underlying cortical metabolite disturbance in ASD, and the detection, diagnosis, and treatment of ASD and other multi-dimensional psychiatric disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Baron-Cohen, S., Wheelwright, S., Skinner, R., Martin, J., & Clubley, E. (2001) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1005653411471 · Cited by 6,450 · cited 4×
“…ASD triad has been reported as genetically heterogeneous (Happé et al., 2006; Ronald et al., 2006; Robinson et al., 2012) Furthermore, the spectrum of the symptom triad, particularly social cognitive domain, are identified in the general population (Baron-Cohen et al., 2001; Ruzich et al., 2015).”
BackgroundInfluentialModel of autism: increased ratio of excitation/inhibition in key neural systems
Rubenstein, J. L. R., & Merzenich, M. M. (2003) · Genes, Brain and Behavior · doi:10.1034/j.1601-183x.2003.00037.x · Cited by 2,768
Critical period plasticity in local cortical circuits
Hensch, T. K. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1787 · Cited by 2,323 · cited 1×
“…12 March 2016 | Volume 9 | Article 14 development, which is supported by studies that demonstrate the excitatory role of GABA in the neurodevelopmental stages preceding glutamate maturation (for extensive reviews, see Hensch, 2005; Ben-Ari et al., 2007; LeBlanc and Fagiolini, 2011).”
BackgroundGABA: A Pioneer Transmitter That Excites Immature Neurons and Generates Primitive Oscillations
Ben-Ari, Y., Gaiarsa, J.-L., Tyzio, R., & Khazipov, R. (2007) · Physiological Reviews · doi:10.1152/physrev.00017.2006 · Cited by 1,304
Bak, L. K., Schousboe, A., & Waagepetersen, H. S. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03913.x · Cited by 1,114
NMDA receptor hypofunction model of schizophrenia
Olney, J. W., Newcomer, J. W., & Farber, N. B. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(99)00029-1 · Cited by 1,020
Lisman, J. E., Coyle, J. T., Green, R. W., Javitt, D. C., Benes, F. M., Heckers, S., & Grace, A. A. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2008.02.005 · Cited by 1,010
Time to give up on a single explanation for autism
Happé, F., Ronald, A., & Plomin, R. (2006) · Nature Neuroscience · doi:10.1038/nn1770 · Cited by 987
Pardo, C. A., & Eberhart, C. G. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00102.x · Cited by 514
Genetic Heterogeneity Between the Three Components of the Autism Spectrum: A Twin Study
RONALD, A., HAPPÉ, F., BOLTON, P., BUTCHER, L. M., PRICE, T. S., WHEELWRIGHT, S., BARON-COHEN, S., & PLOMIN, R. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000215325.13058.9d · Cited by 508 · cited 2×
“In terms of the ASD diagnosis itself, research suggests that the triad of phenotypes is genetically heterogeneous (Happé et al., 2006; Ronald et al., 2006; Robinson et al., 2012).”
BackgroundGlutamate in Schizophrenia: A Focused Review and Meta-Analysis of 1H-MRS Studies
Marsman, A., van den Heuvel, M. P., Klomp, D. W. J., Kahn, R. S., Luijten, P. R., & Hulshoff Pol, H. E. (2013) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr069 · Cited by 457
GABAA Receptor Downregulation in Brains of Subjects with Autism
Fatemi, S. H., Reutiman, T. J., Folsom, T. D., & Thuras, P. D. (2009) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-008-0646-7 · Cited by 439
Rothman, D. L., Behar, K. L., Hyder, F., & Shulman, R. G. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142131 · Cited by 337
Neurochemical correlates of autistic disorder: a review of the literature
Lam, K. S. L., Aman, M. G., & Arnold, L. E. (2006) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2005.03.003 · Cited by 318 · cited 4×
“Cholinergic pathways have been linked to social and behavioral abnormalities, particularly in ASD symptom severity (Lam et al., 2006), and orientation of attention and sensory processing through electrophysiological change detection studies (Orekhova and Stroganova, 2014), calling for further…”
BackgroundInfluentialAutism: A “Critical Period” Disorder?
LeBlanc, J. J., & Fagiolini, M. (2011) · Neural Plasticity · doi:10.1155/2011/921680 · Cited by 301 · cited 4×
“…is especially dangerous during the critical developmental stage in pre- and early postnatal development (Deng et al., 2004; LeBlanc and Fagiolini, 2011), with excitatory/inhibitory imbalance affecting cortical plasticity (Lam et al., 2006; LeBlanc and Fagiolini, 2011; Berger et al., 2013).”
BackgroundInfluentialStahlberg, O., Soderstrom, H., Rastam, M., & Gillberg, C. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0115-1 · Cited by 273
Gaetz, W., Bloy, L., Wang, D. J., Port, R. G., Blaskey, L., Levy, S. E., & Roberts, T. P. L. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2013.05.068 · Cited by 267 · cited 11×
“…Kubas et al., 2012 Left ↓ Harada et al., 2011 ↓ /NAA Harada et al., 2011 /Glu Harada et al., 2011 Motor Left ↓ /Cr Gaetz et al., 2014 Auditory Left ↓ /Cr Gaetz et al., 2014 ↓ /Cr Rojas et al., 2011 Visual Left /Cr Gaetz et al., 2014 Lent Left /NAA Harada et al., 2011 /Glu Harada et al.,…”
BackgroundInfluentialBrieber, S., Neufang, S., Bruning, N., Kamp‐Becker, I., Remschmidt, H., Herpertz‐Dahlmann, B., Fink, G. R., & Konrad, K. (2007) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2007.01799.x · Cited by 253 · cited 1×
“…et al., 2013; Ford and Crewther, 2014), schizotypal traits (Dinsdale et al., 2013; Ford and Crewther, 2014), epilepsy andmental retardation (Aoki et al., 2012), ADHD (Stahlberg et al., 2004; Brieber et al., 2007), bipolar disorder (Stahlberg et al., 2004), and anxiety (Stahlberg et al., 2004).”
BackgroundHarada, M., Taki, M. M., Nose, A., Kubo, H., Mori, K., Nishitani, H., & Matsuda, T. (2011) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-010-1065-0 · Cited by 231
NMDA receptor dysfunction in autism spectrum disorders
Lee, E.-J., Choi, S. Y., & Kim, E. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.10.007 · Cited by 192
Alteration of Plasma Glutamate and Glutamine Levels in Children with High-Functioning Autism
Shimmura, C., Suda, S., Tsuchiya, K. J., Hashimoto, K., Ohno, K., Matsuzaki, H., Iwata, K., Matsumoto, K., Wakuda, T., Kameno, Y., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025340 · Cited by 189
Brain hyper-reactivity to auditory novel targets in children with high-functioning autism
Gomot, M., Belmonte, M. K., Bullmore, E. T., Bernard, F. A., & Baron-Cohen, S. (2008) · Brain · doi:10.1093/brain/awn172 · Cited by 163
Naaijen, J., Lythgoe, D. J., Amiri, H., Buitelaar, J. K., & Glennon, J. C. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.02.009 · Cited by 117
Solomon, M., Olsen, E., Niendam, T., Ragland, J. D., Yoon, J., Minzenberg, M., & Carter, C. S. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.03.005 · Cited by 99
How do glial-neuronal interactions fit into current neurotransmitter hypotheses of schizophrenia?
Kondziella, D., Brenner, E., Eyjolfsson, E. M., & Sonnewald, U. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2006.09.006 · Cited by 83
Metabolite alterations in autistic children: a 1H MR spectroscopy study
Kubas, B., Kułak, W., Sobaniec, W., Tarasow, E., Łebkowska, U., & Walecki, J. (2012) · Advances in Medical Sciences · doi:10.2478/v10039-012-0014-x · Cited by 74
Atypical developmental patterns of brain chemistry in children with Autism Spectrum Disorder
Corrigan, N. M., Shaw, D. W. W., Estes, A. M., Richards, T. L., Munson, J., Friedman, S. D., Dawson, G., Artru, A. A., & Dager, S. R. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1388 · Cited by 54
Cited by
Candidate biomarkers in psychiatric disorders: state of the field
Abi‐Dargham, A., Moeller, S. J., Ali, F., DeLorenzo, C., Domschke, K., Horga, G., Jutla, A., Kotov, R., Paulus, M. P., Rubio, J. M., et al. (2023) · World Psychiatry · doi:10.1002/wps.21078 · Cited by 372
Reduced GABA and altered somatosensory function in children with autism spectrum disorder
Puts, N. A. J., Wodka, E. L., Harris, A. D., Crocetti, D., Tommerdahl, M., Mostofsky, S. H., & Edden, R. A. E. (2017) · Autism Research · doi:10.1002/aur.1691 · Cited by 265
Microglia and Astrocyte Function and Communication: What Do We Know in Humans?
Garland, E. F., Hartnell, I. J., & Boche, D. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.824888 · Cited by 165
“H-MRS detects molecules, such as metabolites and neurotransmitters, based on the unique proton and electron signature of each molecule (Ford and Crewther, 2016).”
BackgroundDeSouza, D. D., Stimpson, K. H., Baltusis, L., Sacchet, M. D., Gu, M., Hurd, R., Wu, H., Yeomans, D. C., Willliams, N., & Spiegel, D. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhz332 · Cited by 25
Late fMRI Response Components Are Altered in Autism Spectrum Disorder
Murray, S. O., Kolodny, T., Schallmo, M.-P., Gerdts, J., & Bernier, R. A. (2020) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2020.00241 · Cited by 7
Metadata
- Authors
- Ford, T. C., & Crewther, D. P.
- Venue
- Frontiers in Molecular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2016-03-09
- Volume
- 9
- Pages
- 14-14
- ISSN
- 1662-5099 (ISSN-L)
- OpenAlex
- W2317961881
- Cited by
- 113
- References
- 27
- FWCI
- 5.29
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.